1 Apr 2026Open access
Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKIPublisher siteNefrología (English Edition), Growth Hormone and Insulin-like Growth Factors
UniversitiesRoby Abdel-Aziz Abdel-Gelil
Active, last published 2026
Roby Abdel-Aziz
Abdel-Gelil
Scholar“Research profile drawn from open scholarly records.”
Minia University
Claim Your Profile0
H-index
0
Citations
Roby has not officially claimed their profile. If you are Roby, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Roby Abdel-Aziz Abdel-Gelil will appear here once their profile is updated.
02 · Reach
Publication output and reach
Roby's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchMinia UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works8 Jan 2026Open access
Dual biomarker strategy with [TIMP-2]·[IGFBP7] and copeptin enhances early diagnosis and risk prediction in HRS-AKIPublisher siteNefrología, Liver Disease and Transplantation
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Roby?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you